NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

  News | News By Subject | News by Disease News By Date | Search News
 Diseases - Osteoarthritis
CombinatoRx, Incorporated (CRXX)'s Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial   10/21/2009  More...
Lubris, Biomodels, LLC Report on Potential New Therapy for Osteoarthritis   10/20/2009  More...
Electrostimulation Techniques For Osteoarthritis: Not Enough Evidence To Recommend, University of Bern Researchers Say   10/7/2009  More...
Duke University Study Suggests Obesity Alone Does Not Cause Knee Osteoarthritis   9/29/2009  More...
Hormone Promises To Keep Joint Injuries From Causing Long-term Osteoarthritis, University of Rochester Medical Center Study   9/14/2009  More...
Pozen, Inc. (POZN) Announces FDA Acceptance of NDA For VIMOVO(TM)   8/31/2009  More...
Genzyme Canada Inc.: Single Injection Approved in Canada for Treatment of OA of the Knee   3/16/2009  More...
FDA Approves Genzyme Corporation (GENZ)'s Synvisc-One for Osteoarthritis of the Knee   2/26/2009  More...
FDA Accepts Nuvo Research Inc. (NRI.TO)'s Resubmission For Pennsaid(R)   2/19/2009  More...
Galapagos NV Delivers Pre-Clinical Candidate Drug In Alliance With GlaxoSmithKline (GSK) And Receives EUR 7.6 Million In Milestone Payments   1/5/2009  More...
Galapagos NV and GlaxoSmithKline (GSK) (JOBS) Expand Osteoarthritis Alliance   12/22/2008  More...
GlaxoSmithKline (GSK) (JOBS), Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Diabetes Drug Double Women's Fracture Risk   12/10/2008  More...
CombinatoRx, Incorporated (CRXX) Provides In-Depth Analysis from Phase 2b Knee Osteoarthritis Study of Synavive (CRx-102) With Clinical Investigators   10/27/2008  More...
Emisphere Technologies, Inc. (EMIS) Announces Initiation of Second Phase III Study for Oral Osteoarthritis Treatment   10/21/2008  More...
Ethnic Differences In Arthritis Due To Obesity, University of Arizona Study   10/20/2008  More...
New Data Across Pfizer Inc. (PFE)’s Pain and Inflammation Portfolio to Be Presented at Upcoming American College of Rheumatology Meeting   10/14/2008  More...
Chondroitin Sulphate Linked To Lower Knee Swelling, Scientists At University of Utah School of Medicine And University of Maryland School of Medicine Say   10/6/2008  More...
CombinatoRx, Incorporated (CRXX) Says Drug Fails Trial, Shares Slump   10/6/2008  More...
CombinatoRx, Incorporated (CRXX) Announces Top-Line Results from Phase 2b Study of Synavive(TM) (CRx-102) for Knee Osteoarthritis   10/6/2008  More...
Dietary Supplements Glucosamine and/or Chondroitin Fare No Better than Placebo in Slowing Structural Damage of Knee Osteoarthritis, University of Utah School of Medicine and National Institutes of Health (NIH) Study   9/30/2008  More...
Popular Surgery Provides No Relief For Osteoarthritis Of The Knee, University of Western Ontario and Lawson Health Research Institute Study Finds   9/11/2008  More...
New Test To Diagnose Osteoarthritis Early, American Chemical Society   8/21/2008  More...
Mesoblast Limited Stem Cells Regrow Knee Cartilage In Severe Post-Menopausal Osteoarthritis   8/12/2008  More...
PL Thomas Release: 5-LOXIN® Proven to Reduce the Symptoms of Osteoarthritis in New Human Study Published in Arthritis Research and Therapy   8/1/2008  More...
Anika Therapeutics (ANIK) Announces Commercial Availability of MONOVISCâ„¢ in Europe   6/30/2008  More...
Eli Lilly and Company (LLY) Release: Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study   6/13/2008  More...
Pomegranate Extract Shows Joint Health Potential, Case Western Reserve University Study   6/6/2008  More...
Nuvo Research Inc. (NRI.TO) and Paladin Labs Inc. (CC:PLB) Release: New Improved Dosing Approved for Pennsaid   6/3/2008  More...
NicOx SA (NCOX.F) Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study   5/28/2008  More...
CombinatoRx, Incorporated (CRXX) Completes Enrollment in Phase 2B Clinical Trial of CRx-102 in Knee Osteoarthritis   5/27/2008  More...
Mesoblast Limited Announce Long-Lasting and Sustained Effect by Allogeneic Cells In Knee Osteoarthritis Preclinical Trials   4/17/2008  More...
Endo Pharmaceuticals (ENDP) Buys Rights to Novartis Corporation (NVS) Product; Upfront Cash Payment of $85M   3/5/2008  More...
NicOx SA (NCOX.F) Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis   3/3/2008  More...
NicOx SA (NCOX.F) Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis   3/3/2008  More...
No Difference Seen With Glucosamine Or Placebo For Hip Osteoarthritis   2/19/2008  More...
New York University, Tel Aviv University Create Non-Invasive Imaging Method For Diagnosing Osteoarthritis   2/12/2008  More...
SantoSolve Reports Positive Phase II Results In Patients With Osteoarthritis   1/24/2008  More...
InfoMedics, Inc. Reports Progress in Patient Feedback Program for Ferring Pharmaceuticals' Osteoarthritis treatment, EUFLEXXA(TM)   1/16/2008  More...
Listen-up Ladies: Don't Postpone Knee-replacement Surgery   1/14/2008  More...
Anika Therapeutics (ANIK) Enrolls First Patient in U.S. Clinical Study for Monoviscâ„¢   1/8/2008  More...
Genzyme Corporation (GENZ) Receives European CE Mark for Single-Treatment Synvisc-One(TM) Only Product of its Kind in Europe to Offer up to Six Months of Pain Relief in OA Knee Pain   12/19/2007  More...
Ferring Pharmaceuticals Studies Show Effectiveness of EUFLEXXA(TM) in Treating Knee Osteoarthritis and Reducing the Pain that Interferes with Daily Activities   12/10/2007  More...
Acologix, Inc. Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis   12/7/2007  More...
Brane Discovery Srl Commences Phase I Trial of BND-11624 for Neuropathic and Osteoarthritic Pain   11/27/2007  More...
Optasia Medical Limited Release: Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device   11/20/2007  More...
Genzyme Corporation (GENZ) Receives FDA Response Letter on Synvisc-One(TM) Approval in U.S. to be Delayed   11/13/2007  More...
Ferring Pharmaceuticals Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis   11/7/2007  More...
Primus Pharmaceuticals, Inc.: New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis   11/7/2007  More...
New Insights into Inflammation in Osteoarthritis   10/29/2007  More...
CombinatoRx, Incorporated (CRXX) Publishes Clinical Study Results of CRx-102 in Hand Osteoarthritis   10/26/2007  More...
Novartis Corporation (NVS) Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis   10/22/2007  More...
Smith & Nephew plc (SNN) Release: New Collaboration to Develop Orthopaedic Adult Stem Cell Therapies   10/10/2007  More...
Health Canada Removes Novartis Pharmaceuticals Canada Inc. (NVS)'s Cox-2 Drug Prexige from the Market over Liver Problems   10/4/2007  More...
FDA Reviews Merck & Co., Inc. (MRK) (Jobs) and Novartis International AG (NVS)'s Osteoporosis Drugs' Effect on Heart   10/2/2007  More...
CombinatoRx, Incorporated (CRXX) Announces Initiation of Phase 2b Clinical Study of CRx-102 in Knee Osteoarthritis   9/26/2007  More...
New Study May Explain Vioxx Side Effects   8/28/2007  More...
New Ferring Pharmaceuticals-Commissioned Report on Trends in Managed Care Coverage of Osteoarthritis Available at no Charge   8/23/2007  More...
Interleukin Genetics Inc. (ILGN) Initiates Study of Genetics of Osteoarthritis with New York University Medical Center   8/17/2007  More...
Using Coxibs and NSAIDs to Treat Osteoarthritis   8/13/2007  More...
A Potential New Disease-Modifying Drug for Osteoarthritis   7/30/2007  More...
Zars, Inc. Initiates Phase 3 Clinical Trial of ThermoProfen   7/26/2007  More...
Oryx Pharmaceuticals Inc. Announces Launch of NAPRELAN(TM)   7/17/2007  More...
Anesiva, Inc. (ANSV) Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee   7/2/2007  More...
Artimplant: Artelon(R) STT Spacer Receives Regulatory Clearance for Marketing in the USA   6/29/2007  More...
NicOx SA (NCOX.F) Initiates Third Pivotal Naproxcinod Phase 3 Study   6/29/2007  More...
Pharmos Corporation (PARS) Commences Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream   6/27/2007  More...
Nuvo Research Inc. (NRI.TO) Provides Update on Discussions with the FDA Related to Pennsaid Approval   6/19/2007  More...
Small Bone Innovations, Inc. Adds Artelon(R) CMC Spacer Arthro to Thumb Osteo- Arthritis Implant Line   6/19/2007  More...
Novartis Corporation (NVS) Release: Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension   6/15/2007  More...
Novel Mechanism Insights and Additional Data on CombinatoRx, Incorporated (CRXX) Drug Candidates to Be Presented at Upcoming EULAR Meeting   6/7/2007  More...
Unigene Laboratories, Inc. (UGNE) Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated   6/5/2007  More...
Emisphere Technologies, Inc. (EMIS) Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis   5/24/2007  More...
IIbuprofen May Increase Likelihood of Heart Problems in Osteoarthritis Patients   4/6/2007  More...
NicOx SA (NCOX.F) Initiates Second Phase 3 Study to Confirm Naproxcinod's Efficacy and Improved Blood Pressure Profile   4/3/2007  More...
CompuMed (CMPD) Participates in 7th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis   4/3/2007  More...
Nuvo Research Inc. (NRI.TO) Announces Further Update on Discussions With the FDA Related to Review of Pennsaid   3/8/2007  More...
AlphaRx Inc. (ALRX) Announces Completion of Phase II Clinical Trial for Indaflex   3/5/2007  More...
Nuvo Research Inc. (NRI.TO) Says FDA Approval For Pennsaid May Be Delayed   2/9/2007  More...
Exercise Has No Effect On Risk Of Knee Osteoarthritis   1/31/2007  More...
Zylera Pharmaceuticals Announces Availability Of RELAMINE For The Treatment Of Osteoarthritis   1/25/2007  More...
Anika Therapeutics (ANIK) Release: ORTHOVISC(R) Clinical Study Commenced To Expand Usage   1/9/2007  More...
Five Prime Therapeutics, Inc. Enters Osteoarthritis And Pulmonary Fibrosis Collaboration With Centocor, Inc. (JNJ); FivePrime Will Receive An Upfront Payment $15M   1/3/2007  More...
Nuvo Research Inc. (NRI.TO) Receives Approvable Letter From U.S. FDA For Pennsaid   12/29/2006  More...
Nuvo Research Inc. (NRI.TO) Licenses Canadian Pennsaid Plus Rights To Subsidiary Of Paladin Labs Inc. (CC:PLB) Squire Pharmaceuticals Inc.   12/22/2006  More...
BioniCare Medical Technologies, Inc. Release: New Published Data Suggest The Ability To Defer Total Knee Replacement For Patients With Knee Osteoarthritis   12/19/2006  More...
FDA Needs More Pozen, Inc. (POZN) Trexima Data; Company To Submit Revised Response To Approvable Letter By Year End   12/13/2006  More...
HealthSonix (HSXI.PK)' Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients   12/13/2006  More...
Smokers Risk More Painful And Progressive Osteoarthritis   12/7/2006  More...
Genzyme Corporation (GENZ) Release: Study Demonstrates One Administration Of Synvisc Improves Osteoarthritis Pain   12/1/2006  More...
Ibex Technologies (IBT.TO) Release: Analysis Of Urinary C2C Distinguishes Between Individuals With Painful Knees And Individuals Identified By MRI To Have Early Osteoarthritis   11/13/2006  More...
EU Approves Novartis AG's Prexige In Osteoarthritis; Plans To File For U.S. Approval In 2007   11/7/2006  More...
NicOx SA (NCOX.F) Naproxcinod Phase 3 OA Trial Meets Primary Endpoints And Shows Encouraging Blood Pressure Profile   10/27/2006  More...
Arthritis Drugs Have Similar Risks And Benefits   10/18/2006  More...
Advanced Bio Surfaces New Knee Implant Offers Long-Awaited Option For Osteoarthritis Sufferers   10/16/2006  More...
DOV Pharmaceutical Announces New Strategic Direction, Bicifadine Clinical Studies Results And Program Updates   10/10/2006  More...
NicOx SA (NCOX.F) Gives Full Details Of Naproxcinod Phase 3 Plan In Osteoarthritis And An Update On Other R&D Programs   9/6/2006  More...
OrthoLogic Corporation (OLGC) Announces Results Of Preliminary Interim Analysis Of Phase 2b Clinical Trial Of Chrysalin(R) (TP508) In Fracture Repair; Terminates Study   8/30/2006  More...
Stellar Pharmaceuticals Inc. (SLX.V) Receives CE Mark For NeoVisc'R'   8/30/2006  More...
Genzyme Corporation (GENZ) Files For European Approval Of Synvisc(R) In Ankle And Shoulder Indications   8/11/2006  More...
Celtic Pharma's Successful Completion Of Second European Phase III Pivotal Trial For IDEA-033, Reacquisition Of North American Rights By IDEA Provides Global Asset With Blockbuster Potential   8/2/2006  More...
Actavis Launches Meloxicam Tablets For The Relief Of Signs And Symptoms Of Osteoarthritis And Rheumatoid Arthritis   7/26/2006  More...
Seikagaku Corporation To Begin Clinical Trials Of Injectable Hyaluronic Acid Gel For Knee Osteoarthritis Treatment In US   7/21/2006  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Final Approval Of Meloxicam Tablets   7/20/2006  More...
Par Pharmaceutical, Inc. Receives Final Approval To Market Meloxicam Tablets   7/20/2006  More...
Lupin Pharmaceuticals, Inc. Announces Approval Of Meloxicam Tablets   7/20/2006  More...
Mylan Laboratories Inc. (MYL) Announces Final Approval For Meloxicam Tablets   7/20/2006  More...
Caraco Pharmaceutical Laboratories, Ltd. (CPD) Announces FDA Approval To Market Generic Mobic(R)   7/20/2006  More...
Genzyme Corporation (GENZ) Release: Positive Synvisc Data Presented At European Conference   6/23/2006  More...
NicOx SA (NCOX.F) Receives World Health Organization Acceptance Of Naproxcinod As Generic Name For HCT 3012, First In A New Class Of Treatments For Osteoarthritis   6/19/2006  More...
Additional Clinical Data On CombinatoRx, Incorporated (CRXX) Drug Candidate CRx-102 To Be Presented At Upcoming EULAR Meeting   6/13/2006  More...
GlaxoSmithKline (GSK) And Galapagos Genomics NV Enter Into Drug Discovery And Development Alliance In Osteoarthritis; Up To EUR 130 Million In Milestone Payments   6/7/2006  More...
Genzyme Corporation (GENZ) Launches 'In Step With SYNVISC' Website To Help Sufferers With Osteoarthritis   6/7/2006  More...
NicOx SA (NCOX.F) Completes Enrolment Of Phase 3 Trial For HCT 3012 In Osteoarthritis Ahead Of Schedule   5/24/2006  More...
Orthogen AG Release: New Therapies Against Osteoarthritis And Rheumatoid Arthritis   5/22/2006  More...
NicOx SA (NCOX.F) Initiates New Trial To Establish HCT 3012 As Osteoarthritis Treatment With Beneficial Blood Pressure Profile   5/4/2006  More...
Pozen, Inc. (POZN) Announces Completion Of Special Protocol Assessment For PN 200   4/21/2006  More...
Labopharm (DDS.TO) Reports Positive Results For Phase III Study On Once-Daily Tramadol; Stock Jumps   4/12/2006  More...
Vitamin K Deficiency Linked To Osteoarthritis   4/11/2006  More...
AlphaRx Inc. (ALRX) And Proprius Pharmaceuticals Announce License Agreement For Indaflex(TM), A Phase II Topical NSAID For Osteoarthritis   4/11/2006  More...
Biodegrable CMC Spacers For Basal Thumb OA Drive Growth At Small Bone Innovations, Inc.   3/24/2006  More...
VirtualScopics, LLC Awarded Global Contract With GlaxoSmithKline (GSK) For Large Osteoarthritis Clinical Trial Program   3/14/2006  More...
Glucosamine, Chondroitin Relieve Moderate-To-Severe Osteoarthritis Pain   3/2/2006  More...
Nuvo Research Inc. (NRI.TO) Announces Pennsaid(R) Data Published In The Journal Of Rheumatology   3/2/2006  More...
Nuvo Research Inc. (NRI.TO) Provides Update On Long-Term Safety Trial For Pennsaid(R)   3/1/2006  More...
National Institutes of Health (NIH) GAIT Study Supports Use Of Glucosamine And Chondroitin For Osteoarthritis Treatment   2/17/2006  More...
Ferring Pharmaceuticals, Inc. Release: Head-to-Head Study Shows EUFLEXXA(TM) Has Greater Tolerability Compared To Synvisc(R) For Osteoarthritis Knee Pain   2/13/2006  More...
DOV Pharmaceutical Announces Initiation Of Phase II Clinical Trial In Osteoarthritis   2/7/2006  More...
Nuvo Research Inc. (NRI.TO) Reports Detailed Phase III Pennsaid(R) Clinical Results   1/16/2006  More...
Nuvo Research Inc. (NRI.TO) Reports Successful Pennsaid(R) Phase III Clinical Trial Results   12/22/2005  More...
NicOx SA (NCOX.F) Announces Initiation Of Phase 3 Trial For HCT 3012 In Osteoarthritis   12/20/2005  More...
Pain Therapeutics (PTIE) Oxytrex Trial Fails To Cut Addiction In Statistically Meaningful Fashion   11/22/2005  More...
VirtualScopics, LLC' Co-authors Two Presentations At The American College of Rheumatology Meeting   11/15/2005  More...
Sanofi-Aventis (France) (SASY.PA) Release: Study Shows That Intra-Articular Hyaluronate Therapy Hyalgan(R) (sodium hyaluronate) Is Effective In Treating Chronic Shoulder Pain Due To Osteoarthritis   11/15/2005  More...
BioniCare Medical Technologies, Inc. Release: New Clinical Data Reaffirms Safety And Efficacy Of BioniCare(R) Knee Device In The Treatment Of Osteoarthritis Of The Knee While Offering Decreased NSAID Usage   11/15/2005  More...
National Institutes of Health (NIH) Study Examines The Efficacy And Safety Of Glucosamine And Chondroitin In Promoting Knee Joint Health   11/15/2005  More...
Ferring Pharmaceuticals A/S Announces Launch Of EUFLEXXA(TM) For Osteoarthritis Knee Pain   11/14/2005  More...
Initial Results Of Leiner Health Products Inc. Funded Study Reveal Glucosamine And Chondroitin Effective In Treating Moderate To Severe Osteoarthritis Knee Pain   11/10/2005  More...
Genzyme Corporation (GENZ) Retains Its Medicare Code And Reimbursement Rate For Synvisc   11/8/2005  More...
ChondroGene Inc. (CDG.V) Release: Blood-based Osteoathritis Biomarker Paper Published   10/25/2005  More...
FDA Accepts Filed Pre-Market Approval Supplement To Expand The Indication For Hyalgan(R) (sodium hyaluronate) To Include Shoulder Pain Due To Osteoarthritis  9/20/2005  More...
Pomegranate Fruit Shown To Slow Cartilage Deterioration In Osteoarthritis  9/1/2005  More...
Paladin Labs Inc. (CC:PLB) To Acquire Canadian License To Pennsaid  8/17/2005  More...
FDA Approves New Use For Celebrex; Pfizer Inc.'s (PFE) Arthritis Drug To Add Warning  8/1/2005  More...
Ferring Pharmaceuticals Obtains Rights To EUFLEXXA(TM)  7/19/2005  More...
Stellar Pharmaceuticals Inc. (SLX.V) And InnoGen Ltd. Sign NeoVisc(R) Licensing Agreement For Turkey  7/14/2005  More...
Pain Therapeutics (PTIE) Completes Patient Enrollment In A Phase III Study Of Remoxy(TM)  6/8/2005  More...
Kaken Pharmaceuticals Obtains Additional Approval For Its Anti-Osteoarthritic Agents  5/20/2005  More...
NPS Pharmaceuticals (NPSP) Reports First Quarter 2005 Operating Results  5/11/2005  More...
Pfizer Inc. (PFE) Statement On Status Of Bextra  5/10/2005  More...
BioniCare Announces Closing Of Series C Preferred Stock Financing With U.S. And Japanese Institutional Investors  5/9/2005  More...
Genzyme Corporation (GENZ) Release: Positive Synvisc Data Published By Cochrane Collaboration  5/5/2005  More...
Vitamin D, Calcium Supplements Don't Cut Fracture Risk For Elderly  4/28/2005  More...
Antares Pharma, Inc. (ANTR) Unveils Its First Proprietary Oral Fast Melt Drug  4/27/2005  More...
Imagenetix, Inc. (IAGX) Release: Dr. Reddy's Laboratories, Inc. (RDY) Launches Celadrin As A Pharmaceutical Product In India  4/13/2005  More...
Lidocaine Patch Found Effective For Knee Pain  3/31/2005  More...
Dermatrends Announces Development Of Ground-breaking Transdermal NSAID Product  3/31/2005  More...
ChondroGene Inc. (CDG.V) Receives Funding Support From NRC-IRAP To Develop A Blood-Based Osteoarthritis Test  3/16/2005  More...
RIKEN Researchers Locate Susceptibility Gene For Osteoarthritis  3/16/2005  More...
Oxford Bioscience Partners Raises $20 Million In Private Placement  3/10/2005  More...
A Shallow Hip Socket Predicts Osteoarthritis Of The Hip  3/3/2005  More...
Sanofi-Synthelabo Inc. Release: First Pilot Study To Show Benefit Using Hyalgan(R) (Sodium Hyaluronate) In The Treatment Of Osteoarthritis Of The Ankle  2/24/2005  More...
Collagen Defect May Trigger Osteoarthritis  2/21/2005  More...
GTx, Inc. (GTXI) Initiates Phase I Clinical Trial For Its Second SARM Ostarine  2/1/2005  More...
Winston Laboratories, Inc. Release: Topical Civamide Cream 0.075% Effectively Reduces Osteoarthritis Pain Without Harmful, Systemic Side Effects  1/25/2005  More...
Gene "Raises Osteoarthritis Risk"  1/10/2005  More...
Given Imaging Ltd. (GIVN) Announces Publication Of NSAID Study Using PillCam(TM) SB In Clinical Gastroenterology And Hepatology  1/10/2005  More...
Asporin Polymorphism Tied To Osteoarthritis  1/10/2005  More...
Genzyme Corporation (GENZ) Completes Purchase Of Synvisc Sales and Marketing Rights  1/6/2005  More...
Pain Therapeutics (PTIE) Meets All Milestones In 2004  12/23/2004  More...
ChondroGene Inc. (CDG.V) And Pfizer Inc. (PFE) Enter Into A New Osteoarthritis Collaboration  12/21/2004  More...
Stellar International Inc. (CC:YYS) Moves To New London, Ontario Facility   12/20/2004  More...
Labopharm (DDS.TO) Finalizes Special Protocol Assessment With FDA  12/16/2004  More...
Triad Therapeutics, Inc. Reports Sale Of p38 Kinase Inflammation Program To Novartis Pharma AG (NVS); $66 Million  12/8/2004  More...
Savient Pharmaceuticals, Inc. (SVNT) Receives FDA Approval For Nuflexxa -1% Sodium Hyaluronate- For The Treatment Of Pain In Osteoarthritis Of The Knee   12/7/2004  More...
McNeil Consumer & Specialty Pharmaceuticals (JNJ) Release: New Study Confirms Benefits Of Acetaminophen As First Line Treatment For Osteoarthritis Pain  12/6/2004  More...
GELITA Health Initiative: New Clinical And Experimental Data Confirm The Importance Of Collagen Hydrolysate In The Treatment Of Degenerative Joint Disease   12/2/2004  More...
Following EMEA Decision To Review Safety Of COX-2 Class, Novartis Pharma AG (NVS) Temporarily Withdraws EU Mutual Recognition Procedure Application For Prexige(R)  11/30/2004  More...
GlaxoSmithKline (GSK) Reviews Novel Therapeutics For CNS Disorders And Confirms Strong Pipeline Momentum  11/23/2004  More...
IHS Bioceuticals, LLC Release: Clinical Studies Show Natural Treatment Aids Arthritis Patients  11/23/2004  More...
Celgene Corporation (CELG) And Galapagos Genomics NV Enter Target Discovery Collaboration  11/18/2004  More...
ChondroGene Inc. (CDG.V) Receives Third Pfizer Inc. (PFE) Milestone Payment   11/15/2004  More...
Pfizer Inc. (PFE) Statement On Bextra(R) (Valdecoxib)   11/10/2004  More...
Tm Bioscience Corporation (CV:TMC) Announces New Collaboration With Genzyme Corporation (GENZ)  11/9/2004  More...
Genzyme Corporation (GENZ) To Acquire Synvisc Sales And Marketing Rights From Wyeth (WYE)  11/4/2004  More...
Pfizer Inc. (PFE) To Sponsor Major New Celebrex Clinical Trial  10/18/2004  More...
Study: Merck & Co.'s (MRK) Arcoxia Appears Safe Medium Term  10/18/2004  More...
Pfizer Inc. (PFE) Provides Information To Healthcare Professionals About Its COX-2 Medicine Bextra(R) (valdecoxib); Risk Of A Very Rare But Serious Skin Reaction  10/15/2004  More...
New Gel Eases Knee Osteoarthritis Pain  10/12/2004  More...
Hako-Med Release: Breakthrough Clinical Study Published For The Pain Treatment Of Osteoarthritis  10/7/2004  More...
Boehringer Ingelheim Pharmaceuticals, Inc. Release: MOBIC Offers Osteoarthritis And Rheumatoid Arthritis Patients An Alternative Treatment Option  10/1/2004  More...
Labopharm (DDS.TO) To Conduct Additional U.S. Phase III Study For Once-Daily Tramadol; Stock Falls  9/22/2004  More...
Cypress Bioscience Inc. (CYPB) And Forest Laboratories, Inc. (FRX) To Commence The Second Phase III Clinical Trial For Milnacipran In The Fourth Quarter  9/9/2004  More...
Common Drug For Knee Pain No Better Than Placebo  8/9/2004  More...
Osteoarthritis Cream Has Short-Term Effect  7/30/2004  More...
Gene Variant Linked To Osteoarthritis In Women  6/23/2004  More...
Bioniche Life Sciences Inc. (BNC.TO) Release: Pharmacoeconomic Study Into Use Of Suplasyn Demonstrates Reduced Pain And Cost-Effectiveness In Treatment Of Patients With Osteoarthritis Of The Knee  6/15/2004  More...
NicOx SA's (FR:N07413) HCT 3012 Shows Equivalent Efficacy To Rofecoxib Without Any Increase Of Systolic Blood Pressure In Osteoarthritis Patients  6/10/2004  More...
Vitamin C May Worsen Arthritis, Study Finds  6/4/2004  More...
Arthritis Foundation Release: Research Presented On Collagen Hydrolysate Shows Promise As Treatment For Osteoarthritis  6/3/2004  More...
Researchers Discover New Clinical Syndrome Leading To Severe Osteoarthritis  5/4/2004  More...